{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:00:53Z","timestamp":1787169653209,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Conselho Nacional de Pesquisa","award":["573839\/2008-5"],"award-info":[{"award-number":["573839\/2008-5"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A high proviral load (PVL) is recognized as a risk factor for human T cell leukemia virus-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP), but there is a lack of prospective studies evaluating whether or not HTLV-1 carriers with high PVL are at risk of developing HAM\/TSP or other HTLV-1-related diseases. Here, we compare the incidence of clinical manifestations and the cytokine levels in 30 HTLV-1 carriers with high (&gt;\u200950,000 copies\/10\n                    <jats:sup>6<\/jats:sup>\n                    PBMC) and an equal number of subjects with low proviral load. Participants were followed for 3 to 16\u00a0years (median of 11\u00a0years). The PVL, IFN-\u03b3, TNF, and IL-10 levels were quantified at entry and at the end of the follow-up. Among the self-reported symptoms in the initial evaluation, only the presence of paresthesia on the hands was more frequent in the group with high PVL (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.04). The production of IFN-\u03b3 was higher in the group with high PVL group (median of 1308 versus 686\u00a0pg\/ml,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.011) when compared with the control group in the first assessment. There was no difference in the occurrence of urinary symptoms or erectile dysfunction, periodontal disease, Sicca syndrome, and neurologic signs between the two groups during the follow-up. The observation that none of the HTLV-1 carriers with high PVL and with exaggerated inflammatory response progressed to HAM\/TSP indicates that other factors in addition to the PVL and an exaggerated immune response are involved in the pathogenesis of HAM\/TSP.\n                  <\/jats:p>","DOI":"10.1007\/s13365-020-00847-y","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T12:03:37Z","timestamp":1588939417000},"page":"520-529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neurologic, clinical, and immunologic features in a cohort of HTLV-1 carriers with high proviral loads"],"prefix":"10.1007","volume":"26","author":[{"given":"Sheila N.","family":"Ferraz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela F.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Abra\u00e3o","family":"Carneiro Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassius J. V.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariele","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia M. A.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2697-8002","authenticated-orcid":false,"given":"Edgar M.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"issue":"9","key":"847_CR1","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1093\/brain\/awt183","volume":"136","author":"H Ando","year":"2013","unstructured":"Ando H, Sato T, Tomaru U, Yoshida M, Utsunomiya A, Yamauchi J, Araya N, Yagishita N, Coler-Reilly A, Shimizu Y, Yudoh K, Hasegawa Y, Nishioka K, Nakajima T, Jacobson S, Yamano Y (2013) Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy. Brain 136(9):2876\u20132887. https:\/\/doi.org\/10.1093\/brain\/awt183","journal-title":"Brain"},{"issue":"1","key":"847_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1590\/S0004-282X2009000100036","volume":"67","author":"AQC Ara\u00fajo","year":"2009","unstructured":"Ara\u00fajo AQC, Leite ACC, Lima MASD, Silva MTT (2009) HTLV-1 and neurological conditions: when to suspect and when to order a diagnostic test for HTLV-1 infection? Arq Neuropsiquiatr 67(1):132\u2013138. https:\/\/doi.org\/10.1590\/S0004-282X2009000100036","journal-title":"Arq Neuropsiquiatr"},{"key":"847_CR3","doi-asserted-by":"publisher","unstructured":"Assone T, Paiva A, Fonseca LAM, Casseb J (2016) Genetic markers of the host in persons living with HTLV-1, HIV and HCV infections. Viruses 8(2). https:\/\/doi.org\/10.3390\/v8020038","DOI":"10.3390\/v8020038"},{"issue":"November 2017","key":"847_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","volume":"36","author":"CRM Bangham","year":"2018","unstructured":"Bangham CRM (2018) Human T cell leukemia virus type 1: persistence and pathogenesis. Annu Rev Immunol 36(November 2017):43\u201371. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053222","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"847_CR5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1212\/WNL.0b013e3181b6bba9","volume":"73","author":"HH Biswas","year":"2009","unstructured":"Biswas HH, Engstrom JW, Kaidarova Z, Garratty G, Gibble JW, Newman BH, Smith JW, Ziman A, Fridey JL, Sacher RA, Murphy EL, For the HTLV Outcomes Study (HOST) (2009) Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy. Neurology 73(10):781\u2013789. https:\/\/doi.org\/10.1212\/WNL.0b013e3181b6bba9","journal-title":"Neurology"},{"issue":"1","key":"847_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00126334-200105010-00001","volume":"27","author":"EM Carvalho","year":"2001","unstructured":"Carvalho EM, Bacellar O, Porto AF, Braga S, Galv\u00e3o-Castro B, Neva F (2001) Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors. Journal of Acquired Immune Deficiency Syndromes (1999) 27(1):1\u20136. https:\/\/doi.org\/10.1097\/00126334-200105010-00001","journal-title":"Journal of Acquired Immune Deficiency Syndromes (1999)"},{"issue":"3","key":"847_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1089\/aid.2006.0140.Clinical","volume":"23","author":"MF Caskey","year":"2008","unstructured":"Caskey MF, Morgan DJ, Porto AF, Giozza SP, Muniz AL, Orge GO, Travassos MJ, Barr\u00f3n Y, Carvalho EM, Glesby MJ (2008) Clinical manifestations associated with HTLV type I infection: a cross-sectional study. Aids 23(3):365\u2013371. https:\/\/doi.org\/10.1089\/aid.2006.0140.Clinical","journal-title":"Aids"},{"issue":"10","key":"847_CR8","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1089\/aid.2006.22.931","volume":"22","author":"CM De Castro-Costa","year":"2006","unstructured":"De Castro-Costa CM, Ara\u00fajo AQC, Barreto MM, Takayanagui OM, Sohler MP, Silva ELMDA, Paula SMBDE et al (2006) Proposal for diagnostic criteria of tropical spastic Paraparesis\/HTLV-I- associated myelopathy (HAM\/TSP). AIDS Res Hum Retrovir 22(10):931\u2013935. https:\/\/doi.org\/10.1089\/aid.2006.22.931","journal-title":"AIDS Res Hum Retrovir"},{"issue":"11","key":"847_CR9","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1086\/430064","volume":"40","author":"MDFSP de Oliveira","year":"2005","unstructured":"de Oliveira MDFSP, Brites C, Ferraz N, Magalhaes P, Almeida F, Bittencourt AL (2005) Infective dermatitis associated with the human T cell Lymphotropic virus type I in Salvador, Bahia, Brazil. Clin Infect Dis 40(11):e90\u2013e96. https:\/\/doi.org\/10.1086\/430064","journal-title":"Clin Infect Dis"},{"issue":"10","key":"847_CR10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.jsxm.2017.08.001","volume":"14","author":"CJV de Oliveira","year":"2017","unstructured":"de Oliveira CJV, Neto JAC, Andrade RCP, Rocha PN, de Carvalho Filho EM (2017) Risk factors for erectile dysfunction in men with HTLV-1. J Sex Med 14(10):1195\u20131200. https:\/\/doi.org\/10.1016\/j.jsxm.2017.08.001","journal-title":"J Sex Med"},{"issue":"1\u20132","key":"847_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0166-0934(01)00445-1","volume":"102","author":"A Deh\u00e9e","year":"2002","unstructured":"Deh\u00e9e A, C\u00e9saire R, D\u00e9sir\u00e9 N, L\u00e9zin A, Bourdonn\u00e9 O, B\u00e9ra O, Plumelle Y, Smadja D, Nicolas JC (2002) Quantitation of HTLV-I Proviral load by a TaqMan real-time PCR assay. J Virol Methods 102(1\u20132):37\u201351. https:\/\/doi.org\/10.1016\/S0166-0934(01)00445-1","journal-title":"J Virol Methods"},{"issue":"2","key":"847_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/AID.2012.0132","volume":"29","author":"MA Demontis","year":"2013","unstructured":"Demontis MA, Hilburn S, Taylor GP (2013) Human T cell Lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases. AIDS Res Hum Retrovir 29(2):359\u2013364. https:\/\/doi.org\/10.1089\/AID.2012.0132","journal-title":"AIDS Res Hum Retrovir"},{"issue":"4","key":"847_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174869","volume":"12","author":"JA Domingos","year":"2017","unstructured":"Domingos JA, Soares LS, Bandeira LM, Bonin CM, Vicente ACP, Zanella L, Puga MAM, Tozetti IA, Motta-Castro ARC, da Cunha RV (2017) Cytokine profile and Proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil. PLoS One 12(4):e0174869. https:\/\/doi.org\/10.1371\/journal.pone.0174869","journal-title":"PLoS One"},{"issue":"4","key":"847_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jbspin.2013.10.006","volume":"81","author":"L Frenzel","year":"2014","unstructured":"Frenzel L, Moura B, Marcais A, Chapdelaine H, Hermine O (2014) HTLV-1-associated Arthropathy treated with anti-TNF-alpha agent. Joint Bone Spine 81(4):360\u2013361. https:\/\/doi.org\/10.1016\/j.jbspin.2013.10.006","journal-title":"Joint Bone Spine"},{"issue":"1","key":"847_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v10010001","volume":"10","author":"N Futsch","year":"2017","unstructured":"Futsch N, Mahieux R, Dutartre H (2017) HTLV-1, the other pathogenic yet neglected human retrovirus: from transmission to therapeutic treatment. Viruses 10(1):1\u201325. https:\/\/doi.org\/10.3390\/v10010001","journal-title":"Viruses"},{"issue":"3","key":"847_CR16","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1086\/649871","volume":"50","author":"GP Garlet","year":"2010","unstructured":"Garlet GP, Giozza SP, Silveira EM, Claudino M, Santos SB, Avila-Campos MJ, Martins W Jr et al (2010) Association of human T lymphotropic virus 1 amplification of periodontitis severity with altered cytokine expression in response to a standard periodontopathogen infection. Clin Infect Dis 50(3):e11\u2013e18. https:\/\/doi.org\/10.1086\/649871","journal-title":"Clin Infect Dis"},{"issue":"3","key":"847_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neurol.2011.12.006","volume":"168","author":"A Gessain","year":"2012","unstructured":"Gessain A, Mahieux R (2012) Tropical spastic Paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects. Rev Neurol 168(3):257\u2013269. https:\/\/doi.org\/10.1016\/j.neurol.2011.12.006","journal-title":"Rev Neurol"},{"issue":"8452","key":"847_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de Th\u00e9 G (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet (London, England) 2(8452):407\u2013410. https:\/\/doi.org\/10.1016\/S0140-6736(85)92734-5","journal-title":"Lancet (London, England)"},{"issue":"3","key":"847_CR19","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1128\/IAI.71.3.1185-1193.2003","volume":"71","author":"JAS Gomes","year":"2003","unstructured":"Gomes JAS, Bahia-Oliveira LMG, Rocha MOC, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R (2003) Evidence that development of severe cardiomyopathy in human Chagas\u2019 disease is due to a Th1-specific immune response. Infect Immun 71(3):1185\u20131193. https:\/\/doi.org\/10.1128\/IAI.71.3.1185-1193.2003","journal-title":"Infect Immun"},{"issue":"7","key":"847_CR20","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/jmv.22087","volume":"83","author":"MFR Grassi","year":"2011","unstructured":"Grassi MFR, Olavarria VN, de Almeida Kruschewsky R, Mascarenhas RE, Dourado I, Correia LCL, de Castro-Costa CM, Galv\u00e3o-Castro B (2011) Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patients according to new diagnostic criteria of HAM\/TSP. J Med Virol 83(7):1269\u20131274. https:\/\/doi.org\/10.1002\/jmv.22087","journal-title":"J Med Virol"},{"issue":"2","key":"847_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2249.2006.03150.x","volume":"145","author":"JB Guerreiro","year":"2006","unstructured":"Guerreiro JB, Santos SB, Morgan DJ, Porto AF, Muniz AL, Ho JL, Teixeira AL, Teixeira MM, Carvalho EM (2006) Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)\/tropical spastic paraparesis (HAM\/TSP) disease from HTLV-1 carrier state. Clin Exp Immunol 145(2):296\u2013301. https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03150.x","journal-title":"Clin Exp Immunol"},{"issue":"16","key":"847_CR22","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685\u20131695. https:\/\/doi.org\/10.1056\/NEJMra043430","journal-title":"N Engl J Med"},{"issue":"2","key":"847_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010.Research","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap) - a metadata driven methodology and workflow process for providing translational research informatict support. J Biomed Inform 42(2):377\u2013381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.Research","journal-title":"J Biomed Inform"},{"issue":"2","key":"847_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1006861","volume":"14","author":"H Kagdi","year":"2018","unstructured":"Kagdi H, Demontis MA, Ramos JC, Taylor GP (2018) Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T-lymphotropic virus type 1 infection. PLoS Pathog 14(2):1\u201325. https:\/\/doi.org\/10.1371\/journal.ppat.1006861","journal-title":"PLoS Pathog"},{"key":"847_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8402059","volume":"2016","author":"CM Lima","year":"2016","unstructured":"Lima CM, Santos S, Dourado A, Carvalho NB, Bittencourt V, Lessa MM, Siqueira I, Carvalho EM (2016) Association of Sicca syndrome with proviral load and proinflammatory cytokines in HTLV-1 infection. J Immunol Res 2016:1\u20136. https:\/\/doi.org\/10.1155\/2016\/8402059","journal-title":"J Immunol Res"},{"issue":"2","key":"847_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v8020031","volume":"8","author":"JL Martin","year":"2016","unstructured":"Martin JL, Maldonado JO, Mueller JD, Zhang W, Mansky LM (2016) Molecular studies of HTLV-1 replication: an update. Viruses 8(2):1\u201322. https:\/\/doi.org\/10.3390\/v8020031","journal-title":"Viruses"},{"issue":"1","key":"847_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s13365-016-0484-x","volume":"23","author":"ML Martins","year":"2017","unstructured":"Martins ML, Guimar\u00e3es JC, Ribas JG, Romanelli LCF, de Freitas Carneiro-Proietti AB (2017) Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM\/TSP: what is its relevance as a prognostic marker for neurologic disease? Journal of NeuroVirology 23(1):125\u2013133. https:\/\/doi.org\/10.1007\/s13365-016-0484-x","journal-title":"Journal of NeuroVirology"},{"issue":"3","key":"847_CR28","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/13550280152403272","volume":"7","author":"T Matsuzaki","year":"2001","unstructured":"Matsuzaki T, Nakagawa M, Nagai M, Usuku K, Higuchi I, Arimura K, Kubota H, Izumo S, Akiba S, Osame M (2001) HTLV-1 Proviral load correlates with progression of motor disability in HAM\/TSP: analysis of 239 HAM\/TSP patients including 64 patients followed up for 10 years. Journal of NeuroVirology 7(3):228\u2013234. https:\/\/doi.org\/10.1080\/13550280152403272","journal-title":"Journal of NeuroVirology"},{"issue":"3","key":"847_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/ard.55.3.193","volume":"55","author":"S Motokawa","year":"1996","unstructured":"Motokawa S, Hasunuma T, Tajima K, Krieg AM, Ito S, Iwasaki K, Nishioka K (1996) High prevalence of arthropathy in HTLV-I carriers on a Japanese Island. Ann Rheum Dis 55(3):193\u2013195 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8712884","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"847_CR30","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CRM, Izumo S, Osame M (1998) Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol 4(6):586\u2013593 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10065900","journal-title":"J Neurovirol"},{"issue":"2","key":"847_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0165-5728(93)90001-F","volume":"42","author":"S Nakamura","year":"1993","unstructured":"Nakamura S, Nagano I, Yoshioka M, Shimazaki S, Onodera J, Kogure K (1993) Detection of tumor necrosis factor-\u03b1-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy. J Neuroimmunol 42(2):127\u2013130. https:\/\/doi.org\/10.1016\/0165-5728(93)90001-F","journal-title":"J Neuroimmunol"},{"issue":"3","key":"847_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1365-2249.2008.03869.x","volume":"156","author":"MCF Nascimento","year":"2009","unstructured":"Nascimento MCF, Primo J, Bittencourt A, Siqueira I, De F\u00e1tima Oliveira M, Meyer R, Schriefer A, Santos SB, Carvalho EM (2009) Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy\/tropical spastic Paraparesis. Clin Exp Immunol 156(3):455\u2013462. https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03869.x","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"847_CR33","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1089\/AID.2016.0296","volume":"33","author":"HVP d C Neco","year":"2017","unstructured":"Neco HVP d C, da Silva Teixeira VG, da Trindade ACL, Magalh\u00e3es PMR, de Lorena VMB, Castellano LRC, de Souza JR, Vasconcelos LR, de Moura PMMF, de Morais CNL (2017) Mediators go together: high production of CXCL9, CXCL10, IFN-\u03b3, and TNF-\u03b1 in HTLV-1-associated myelopathy\/tropical spastic paraparesis. AIDS Res Hum Retrovir 33(11):1134\u20131139. https:\/\/doi.org\/10.1089\/AID.2016.0296","journal-title":"AIDS Res Hum Retrovir"},{"issue":"April","key":"847_CR34","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3389\/fmicb.2019.00885","volume":"10","author":"S Nozuma","year":"2019","unstructured":"Nozuma S, Jacobson S (2019) Neuroimmunology of human T-lymphotropic virus type 1-associated myelopathy\/tropical spastic paraparesis. Front Microbiol 10(April):885. https:\/\/doi.org\/10.3389\/fmicb.2019.00885","journal-title":"Front Microbiol"},{"issue":"1\u20132","key":"847_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jns.2005.05.010","volume":"237","author":"S Olindo","year":"2005","unstructured":"Olindo S, L\u00e9zin A, Cabre P, Merle H, Saint-Vil M, Kaptue ME, Signate A, C\u00e9saire R, Smadja D (2005) HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM\/TSP patients: a marker of disease progression. J Neurol Sci 237(1\u20132):53\u201359. https:\/\/doi.org\/10.1016\/j.jns.2005.05.010","journal-title":"J Neurol Sci"},{"key":"847_CR36","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1001\/archneur.63.11.1560","volume":"63","author":"S Olindo","year":"2006","unstructured":"Olindo S, Cabre P, L\u00e9zin A, Merle H, Saint-Vil M, Signate A, Bonnan M, Chalon A, Magnani L, Cesaire R, Smadja D (2006) Natural history of human T-lymphotropic virus 1\u2013associated myelopathy. Arch Neurol 63:1560\u20131566. https:\/\/doi.org\/10.1001\/archneur.63.11.1560","journal-title":"Arch Neurol"},{"issue":"2","key":"847_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cyto.2013.12.016","volume":"66","author":"WN Oliveira","year":"2014","unstructured":"Oliveira WN, Ribeiro LE, Schrieffer A, Machado P, Carvalho EM, Bacellar O (2014) The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis. Cytokine 66(2):127\u2013132. https:\/\/doi.org\/10.1016\/j.cyto.2013.12.016","journal-title":"Cytokine"},{"issue":"8488","key":"847_CR38","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet (London, England) 1(8488):1031\u20131032. https:\/\/doi.org\/10.1016\/S0140-6736(86)91298-5","journal-title":"Lancet (London, England)"},{"issue":"1","key":"847_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-017-1224-1","volume":"19","author":"JM Pandya","year":"2017","unstructured":"Pandya JM, Lundell AC, Andersson K, Nordstr\u00f6m I, Theander E, Rudin A (2017) Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker. Arthritis Res Ther 19(1):1\u201312. https:\/\/doi.org\/10.1186\/s13075-017-1224-1","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"847_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jcv.2011.02.004","volume":"51","author":"SKW Poetker","year":"2011","unstructured":"Poetker SKW, Porto AF, Giozza SP, Muniz AL, Caskey MF, Carvalho EM, Glesby MJ (2011) Clinical manifestations in individuals with recent diagnosis of HTLV type I infection. J Clin Virol 51(1):54\u201358. https:\/\/doi.org\/10.1016\/j.jcv.2011.02.004","journal-title":"J Clin Virol"},{"issue":"12","key":"847_CR41","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci 77(12):7415\u20137419. https:\/\/doi.org\/10.1073\/pnas.77.12.7415","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"847_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0091154","volume":"9","author":"C Poveda","year":"2014","unstructured":"Poveda C, Fresno M, Giron\u00e8s N, Martins-Filho OA, Ram\u00edrez JD, Santi-Rocca J, Marin-Neto JA, Morillo CA, Rosas F, Guhl F (2014) Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (A benefit trial sub-study). PLoS One 9(3):1\u20138. https:\/\/doi.org\/10.1371\/journal.pone.0091154","journal-title":"PLoS One"},{"issue":"May","key":"847_CR43","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3389\/fmicb.2018.00795","volume":"9","author":"MAF Queiroz","year":"2018","unstructured":"Queiroz MAF, Azevedo VN, da Ednelza SGA, Moura TCF, Guimar\u00e3es Ishak MDO, Ishak R, Vallinoto ACR, Martins Feitosa RN (2018) IFNG +874A\/T polymorphism among asymptomatic HTLV-1-infected individuals is potentially related to a worse prognosis. Front Microbiol 9(May):795. https:\/\/doi.org\/10.3389\/fmicb.2018.00795","journal-title":"Front Microbiol"},{"issue":"4","key":"847_CR44","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/eji.1830270403","volume":"27","author":"W Rudin","year":"1997","unstructured":"Rudin W, Favre N, Bordmann G, Ryffel B (1997) Interferon-\u03b3 is essential for the development of cerebral malaria. Eur J Immunol 27(4):810\u2013815. https:\/\/doi.org\/10.1002\/eji.1830270403","journal-title":"Eur J Immunol"},{"issue":"March","key":"847_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2334-4-7","volume":"4","author":"SB Santos","year":"2004","unstructured":"Santos SB, Porto AF, Muniz AL, de Jesus AR, Magalh\u00e3es E, Melo A, Dutra WO, Gollob KJ, Carvalho EM (2004) Exacerbated inflammatory cellular immune response characteristics of HAM\/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis 4(March):7. https:\/\/doi.org\/10.1186\/1471-2334-4-7","journal-title":"BMC Infect Dis"},{"issue":"3","key":"847_CR46","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000097259","volume":"13","author":"SB Santos","year":"2006","unstructured":"Santos SB, Porto AF, Muniz AL, Luna T, Nascimento MC, Guerreiro JB, Oliveira-Filho J, Morgan DJ, Carvalho EM (2006) Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1. Neuroimmunomodulation 13(3):145\u2013151. https:\/\/doi.org\/10.1159\/000097259","journal-title":"Neuroimmunomodulation"},{"issue":"11","key":"847_CR47","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/jmv.23341","volume":"84","author":"SB Santos","year":"2012","unstructured":"Santos SB, Oliveira P, Luna T, Souza A, Nascimento M, Siqueira I, Tanajura D, Muniz AL, Glesby MJ, Carvalho EM (2012) Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection. J Med Virol 84(11):1809\u20131817. https:\/\/doi.org\/10.1002\/jmv.23341","journal-title":"J Med Virol"},{"issue":"10","key":"847_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0002479","volume":"7","author":"T Sato","year":"2013","unstructured":"Sato T, Coler-Reilly A, Utsunomiya A, Araya N, Yagishita N, Ando H, Yamauchi J, Inoue E, Ueno T, Hasegawa Y, Nishioka K, Nakajima T, Jacobson S, Izumo S, Yamano Y (2013) CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy\/tropical spastic Paraparesis. PLoS Negl Trop Dis 7(10):1\u201311. https:\/\/doi.org\/10.1371\/journal.pntd.0002479","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"847_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.actatropica.2012.09.012","volume":"125","author":"ALB Starling","year":"2013","unstructured":"Starling ALB, Martins-Filho OA, Lambertucci JR, Labanca L, de Souza Pereira SR, Teixeira-Carvalho A, Martins ML, Ribas JG, Carneiro-Proietti ABF, Gon\u00e7alves DU (2013) Proviral load and the balance of serum cytocines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Acta Trop 125(1):75\u201381. https:\/\/doi.org\/10.1016\/j.actatropica.2012.09.012","journal-title":"Acta Trop"},{"issue":"3","key":"847_CR50","first-page":"264","volume":"16","author":"M Taghaddosi","year":"2013","unstructured":"Taghaddosi M, Rahim Rezaee SA, Rafatpanah H, Rajaei T, Hosseini RF, Narges V (2013) Association between HLA class I alleles and proviral load in HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patients in Iranian population. Iranian Journal of Basic Medical Sciences 16(3):264\u2013267 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24470874","journal-title":"Iranian Journal of Basic Medical Sciences"},{"issue":"1","key":"847_CR51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/cid\/civ229","volume":"61","author":"D Tanajura","year":"2015","unstructured":"Tanajura D, Castro N, Oliveira P, Neto A, Muniz A, Carvalho NB, Orge G, Santos S, Glesby MJ, Carvalho EM (2015) Neurological manifestations in human T-cell lymphotropic virus type 1 (HTLV-1)-infected individuals without HTLV-1-associated myelopathy\/tropical spastic paraparesis: a longitudinal cohort study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 61(1):49\u201356. https:\/\/doi.org\/10.1093\/cid\/civ229","journal-title":"Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America"},{"issue":"2","key":"847_CR52","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/nau.22952","volume":"36","author":"O Troisgros","year":"2017","unstructured":"Troisgros O, Barnay JL, Darbon-Naghibzadeh F, Olive P, Ren\u00e9-Corail P (2017) Retrospective clinic and urodynamic study in the neurogenic bladder dysfunction caused by human T cell lymphotrophic virus type 1 associated myelopathy\/tropical spastic Paraparesis (HAM\/TSP). Neurourol Urodyn 36(2):449\u2013452. https:\/\/doi.org\/10.1002\/nau.22952","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"847_CR53","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1182\/blood-2016-06-686618","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H (1977) Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50(3):481\u2013492. https:\/\/doi.org\/10.1182\/blood-2016-06-686618","journal-title":"Blood"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-020-00847-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-020-00847-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-020-00847-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T19:05:14Z","timestamp":1620414314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-020-00847-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1007\/s13365-020-00847-y","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"assertion":[{"value":"26 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research ethics committee of Federal University of Bahia (UFBA) approved this study. Written consent for the study was obtained from all individuals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}